Contact Dermatitis Clinical Trial
Official title:
Randomized Controlled Trial of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
Testing the effectiveness and safety of cosmetics with niacinamide in irritant contact dermatitis: A Randomised, Controlled Trial will be conducted at USSM. Healthy volunteers will be included (at least 25) and test sites are forearms. Sodium lauryl sulphate will be used to induce contact dermatitis and participants will be measured for 7 days
| Status | Recruiting |
| Enrollment | 25 |
| Est. completion date | July 2024 |
| Est. primary completion date | June 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 50 Years |
| Eligibility | Inclusion Criteria: - young, healthy volunteers who gave written informed consent Exclusion Criteria: - skin disease, skin damage on measurement sites, use of corticosteroids and immunomodulators a month prior to the inclusion and during the trial, non-adherence to the trial protocol, exposure to artificial UV radiation, pregnancy and lactation |
| Country | Name | City | State |
|---|---|---|---|
| Croatia | University of Split School of Medicine | Split |
| Lead Sponsor | Collaborator |
|---|---|
| University of Split, School of Medicine |
Croatia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | tewameter | measurement of transepidermal water loss on skin, objective and non invasive | day 1- day 7 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00371163 -
Molecular and Cellular Characterization of Spongiotic Dermatitis
|
N/A | |
| Completed |
NCT02028208 -
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
|
Phase 2 | |
| Not yet recruiting |
NCT04853823 -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
|
Phase 1 | |
| Completed |
NCT02700373 -
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03089775 -
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
|
Phase 1 | |
| Completed |
NCT04438135 -
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
|
N/A | |
| Recruiting |
NCT06189144 -
Testing an Intervention in Irritative Contact Dermatitis
|
N/A | |
| Completed |
NCT04921163 -
Children With Aluminium Contact Allergy: Oral Exposure Study
|
N/A | |
| Not yet recruiting |
NCT02026700 -
Bariederm Cream in Chronic Contact Dermatitis
|
N/A | |
| Completed |
NCT02028182 -
Clinical Evaluation of Lyral® Dose Response Study
|
Phase 2 | |
| Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A | |
| Completed |
NCT00646867 -
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
|
N/A | |
| Withdrawn |
NCT01518348 -
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
|
Phase 3 | |
| Recruiting |
NCT03705182 -
Prevention of Dermatitis in Epoxy Exposed Workers
|
N/A | |
| Terminated |
NCT03198390 -
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
|
||
| Completed |
NCT00614289 -
Novel Topical Treatment of Hand Dermatitis (Eczema)
|
Phase 1 | |
| Recruiting |
NCT06387472 -
DermAI to Evaluate Human Factor of Testing
|
N/A | |
| Completed |
NCT00640250 -
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
|
Phase 2 | |
| Completed |
NCT00640614 -
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
|
Phase 3 | |
| Recruiting |
NCT06177314 -
Molecular Diagnosis of Allergic Contact Dermatitis
|